entertainment -WSS

entertainment

author：entertainment 2025-09-28 15:06:41 - browse：16741

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： The history of OxyContin, told through Purdue Pharma documents

WSS

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

At ASCO, AstraZeneca reports strong data for breast cancer drug

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Kim Kardashian sparks debate on benefits of full

Change Healthcare can notify patients about the breach, HHS says

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

focus

entertainment

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Walensky prepares to leave CDC — and Congress — behind

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Virginia high school admissions case could be legal follow

Kim Kardashian sparks debate on benefits of full

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ASCO: Palliative care found as helpful given virtually as in person

Novavax promises a turnaround & Lilly roils the obesity market

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

hotspot

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Listen: Your guide to Wegovy's blockbuster heart study

ASCO: AstraZeneca says CAR

TB outbreak tied to bone grafts underscores testing shortcomings

Kim Kardashian sparks debate on benefits of full

Genentech weighs delaying cancer therapy after drug pricing law

explore

Wikipedia

hotspot

Wikipedia